Broker Recommendations
Berenberg downgrades DFS, prefers Dunelm
Analysts at Berenberg downgraded their recommendation for shares of DFS Furniture from 'buy' to 'hold' on anticipation that management's guidance for improved demand in mid-2024 would prove premature.
Berenberg impressed by "exceptional" dealmaking at Diploma
Berenberg has hiked its target price for controls, seals and life sciences equipment firm Diploma by 16%, saying there is "a lot to like" about this week's acquisition of US-based specialty fasteners business Peerless.
JD Sports update provides 'sense of relief', says Shore Capital
Shore Capital has reiterated its 'buy' rating for JD Sports after a reassuring trading update from the sportswear and footwear retailer, which has given the stock a boost as it recovers after a profit warning at the start of the year.
Citi sees more than 20% upside for Ascential, stays at 'buy'
Analysts at Citi told clients they saw more than 20% upside in shares of Ascential, when not more.
RBC Capital cuts Dr Martens target price
RBC Capital Markets cut its price target on Dr Martens on Wednesday to 85p from 100p as it lowered its estimates for FY24-26 earnings per share by 7% to 10%.
JPMorgan puts IAG on ‘positive catalyst watch’ ahead of Q1 results
JPMorgan Cazenove placed shares of BA and Iberia owner IAG on ‘positive catalyst watch’ on Wednesday ahead of first-quarter results and following minor changes to estimates published yesterday.
RBC Capital downgrades Mobico to 'sector perform'
RBC Capital Markets downgraded Mobico on Tuesday to ‘sector perform’ from ‘outperform’ and cut the price target to 80p from 110p following the company’s update a day earlier.
JPMorgan puts Auto Trader on 'negative catalyst watch'
Auto Trader slumped on Tuesday as JPMorgan Cazenove placed the shares on ‘negative catalyst watch’ ahead of FY24 results in May.
Goldman Sachs downgrades Dr Martens to ‘sell’
Goldman Sachs downgraded Dr Martens to ‘sell’ from ‘neutral’ on Tuesday and cut the price target to 87p from 93p.
Experian 'top pick', says JPMorgan
JPMorgan Cazenove said on Monday that Experian was its top pick in the European business services sector, along with Bureau Veritas, both of which it rates at ‘overweight’.
JPMorgan places Ashtead on ‘positive catalyst watch’ ahead of CMD
JPMorgan Cazenove placed Ashtead on ‘positive catalyst watch’ on Monday ahead of its capital markets day in Atlanta on 29 April, as it expects the stock to outperform into/on the event.
RBC Capital downgrades St James's Place, slashes price target
RBC Capital Markets downgraded St James’s Place on Friday to ‘sector perform’ from ‘outperform’ and slashed the price target to 500p from 900p.
Berenberg downgrades Redrow on limited upside
Berenberg has cut its rating for housebuilder Redrow from 'buy' to 'hold' following the company's announced merger with Barratt Developments.
Berenberg ups targets for Vistry but risks remain
Berenberg has hiked its target price for partnerships-focused affordable-housing builder Vistry by 15% but kept a 'hold' rating on the stock, saying the company is "well positioned, but delivery risk remains".
RBC Capital downgrades Redrow to ‘sector perform’
RBC Capital Markets downgraded Redrow on Thursday to ‘sector perform’ from ‘outperform’ following a period of outperformance and the fact the share price is now linked to that of Barratt Developments.
RBC Capital upgrades IAG to 'outperform'
RBC Capital Markets upgraded BA and Iberia owner IAG on Thursday to ‘outperform’ from ‘sector perform’ and lifted the price target to 220p from 200p.
Berenberg lifts Close Brothers target as regulatory risks reduce
Shares in Close Brothers Group continued to surge on Wednesday after the merchant bank's first-half results in which the company eased investors' concerns about an upcoming regulatory probe, with Berenberg providing an extra boost after lifting its target price for the stock.
HSBC 'impressed' by quality of Elementis portfolio
HSBC upgraded Elementis to ‘buy’ on Wednesday and lifted the price target to 170p from 150p as it said it was impressed by the company’s portfolio quality and management execution "amid a challenging macro and weak end markets".
RBC lifts Sabre Insurance forecasts after strong 2023
RBC Capital Markets has lifted its target price for Sabre Insurance from 200p to 220p and reiterated an 'outperform' rating after the company's well-received annual results, hailing the company's ability to continue winning volumes profitably.
RBC Capital upgrades Vistry to ‘sector perform’
RBC Capital Markets upgraded its stance on Vistry on Tuesday as it took a fresh look at the house housebuilder following full-year results.